![]() Benitec Biopharma Benitec Biopharma is a biotechnology company developing a therapeutic platform that combines RNA interference with gene therapy. | Resverlogix Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. | ![]() Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology. | |
Founding Date | Founding Date 2001 | Founding Date 2001 | Founding Date 1995 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Hayward, US HQ Melbourne, AU Louisville, US | Locations Calgary, CA HQ San Francisco, US | Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more |
Employees | Employees 14 | Employees 19 | Employees 20216% increase |
Valuation ($) | Valuation ($) 192 m | Valuation ($) 12.9 m | Valuation ($) 737.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $49.8m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $274k (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $50k (FY, 2025) | Gross profit $49.5m (FY, 2025) |
Net income | Net income ($37.9m) (FY, 2025) | Net income ($7.8m) (FY, 2025) | Net income ($50.3m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 36.3m | Total funding raised $ 10m | Total funding raised $ 244.7m |
Resverlogix is a clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses.
View company
Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
View company